Medium materiality6/10
Morgan Stanley Starts Achieve Life Sciences (ACHV) at Overweight
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Morgan Stanley initiates ACHV with an Overweight rating and a $13 target; current price around $6.69. Analyst: Maxwell Skor.
- Morgan Stanley initiates ACHV at Overweight; target $13; price $6.69.
- Analyst: Maxwell Skor.
Key facts
- 01
Target: $13
- 02
Posted price: $6.69
- 03
Analyst firm: Morgan Stanley
- 04
Analyst: Maxwell Skor
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.